We observed that the development of colorectal neoplasia is associated with diminished serum acid-activated latent TGF-β1 levels in CRC patients compared to healthy controls with homozygous CC genotypes and increased TGFB1 gene mRNA levels in distant metastases. This evidence concerns the gene TGFB1 and colorectal carcinoma.